News
News releases on January 10, 2022, page 3
Every news release public companies put out on January 10, 2022 (UTC): 517 news releases, newest first. Open any release to read it.
WSFS Financial Corporation Announces Fourth Quarter 2021 Earnings Release Date and Conference Call
WSFS Financial Corporation · Jan 10, 2022
Westward Gold Announces Listing on the OTCQB Venture Market
Westward Gold Inc · Jan 10, 2022
Western Digital to Announce Second Quarter Fiscal 2022 Financial Results on January 27, 2022
Western Digital Corporation · Jan 10, 2022
Washington Trust Announces Date of Fourth Quarter 2021 Earnings Release, Conference Call and Webcast
Washington Trust Bancorp, Inc. · Jan 10, 2022
Wallbridge Mining Announces 2022 Exploration Program at Flagship Properties on Detour-Fenelon Gold Trend
Wallbridge Mining Co. Ltd. · Jan 10, 2022
Vivid Seats Reaches 100 Millionth Ticket Milestone
Vivid Seats Inc. · Jan 10, 2022
VirTra Receives Orders from Two Foreign Countries Totaling $2.7 Million
VirTra, Inc. · Jan 10, 2022
Viper Energy Partners LP, a Subsidiary of Diamondback Energy, Inc., Schedules Fourth Quarter 2021 Conference Call for February 23, 2022
Viper Energy, Inc. · Jan 10, 2022
Viking Therapeutics Announces Initiation of Phase 1 Clinical Trial of VK2735, Company's Lead Dual GLP-1/GIP Receptor Agonist
Viking Therapeutics, Inc. · Jan 10, 2022
Veru Announces FDA Grant of Fast Track Designation for Enobosarm for the Treatment of AR+ ER+ HER2- Metastatic Breast Cancer
Veru Inc. · Jan 10, 2022
Varonis Announces Date of Fourth Quarter and Full-Year 2021 Financial Results
Varonis Systems, Inc. · Jan 10, 2022
U.S. Energy Corp. Announces Closing of Transformative Acquisitions
U.S. Energy Corp. · Jan 10, 2022
Upwork to Report Fourth Quarter and Full Year 2021 Financial Results on February 10, 2022
Upwork Inc. · Jan 10, 2022
Upwork Partners with Catch to Expand Freelancers’ Access to Benefits
Upwork Inc. · Jan 10, 2022
Upland Software Acquires Objectif Lune
Upland Software, Inc. · Jan 10, 2022
Ultragenyx Reports Preliminary 2021 Revenue and 2022 Revenue Guidance for Crysvita® in Ultragenyx Territories* And Dojolvi® Globally; Pro...
Ultragenyx Pharmaceutical Inc. · Jan 10, 2022
Twist Bioscience’s Comprehensive DNA Synthesis Capabilities Expanded as Industry-Leading Enzymatic Synthesis Process Unveiled at Annual J...
Twist Bioscience Corporation · Jan 10, 2022
Twin Vee PowerCats Wholly Owned Subsidiary Forza X1 and American Battery Solutions Sign a 5-year Agreement to Supply Forza X1’s New Elect...
Twin Vee PowerCats Co. · Jan 10, 2022
TScan Outlines 2022 Priorities as Programs Enter Clinic
TScan Therapeutics, Inc. · Jan 10, 2022
TrustCo to Release Fourth Quarter 2021 Results on January 24, 2022; Conference Call on January 25, 2022
TrustCo Bank Corp NY · Jan 10, 2022
Trinity Capital Inc. Sets a Record with $757 Million in New Commitments for 2021
Trinity Capital Inc. · Jan 10, 2022
Trigon Metals Announces Upsizing Of Private Placement Financing to C$4 Million
Safi Silver Corp. · Jan 10, 2022
Treace Medical Concepts Provides 2021 Preliminary Sales Results
Treace Medical Concepts, Inc. · Jan 10, 2022
Travere Therapeutics Provides Corporate Update and 2022 Outlook
Travere Therapeutics, Inc. · Jan 10, 2022
Tradeweb Announces Fourth Quarter 2021 Earnings Date
Tradeweb Markets Inc. · Jan 10, 2022
T-Mobile Acquires Rideshare Advertising Network, Octopus Interactive
T-Mobile US, Inc. · Jan 10, 2022
Tiziana Enrolls Second Patient in Ongoing Intranasal Foralumab Evaluation for Secondary Progressive Multiple Sclerosis
Tiziana Life Sciences Ltd · Jan 10, 2022
Titan Mining Extends Credit Facility Maturity Dates
Titan Mining Corp. · Jan 10, 2022
Tilray, Inc. Reports Profitable Second Quarter Fiscal Year 2022 Financial Results
Tilray Brands, Inc. · Jan 10, 2022
The Simply Good Foods Company Announces Exercise of Private Warrants by Conyers Park
The Simply Good Foods Company · Jan 10, 2022
Theravance Biopharma, Inc. Announces Enrollment of First Patient in YUPELRI® Phase 4 Study
Theravance Biopharma, Inc. · Jan 10, 2022
The Joint Corp. Reports 2021 Operating Metrics
The Joint Corp. · Jan 10, 2022
The Beauty Health Company Appoints Kellie Sears as Chief Human Resources Officer
SkinHealth Systems Inc. · Jan 10, 2022
Texas Capital Bancshares, Inc. Announces Launch of Texas Capital Securities
Texas Capital Bancshares, Inc. · Jan 10, 2022
TeraWulf Launches Philanthropic Foundation Focused on Improving Social Health, the Environment and Sustainability Initiatives
TeraWulf Inc. · Jan 10, 2022
Tenaya Therapeutics Provides 2022 Business Updates
Tenaya Therapeutics, Inc. · Jan 10, 2022
Take-Two and Zynga to Combine, Bringing Together Best-in-Class Intellectual Properties and a Market-Leading, Diversified Mobile Publishin...
Take-Two Interactive Software, Inc. · Jan 10, 2022
Surrozen Announces Key 2022 Milestones for Lead Programs and Acceleration of Research Pipeline
Surrozen, Inc. · Jan 10, 2022
Surgery Partners Reaffirms 2021 and 2022 Full Year Guidance; David T. Doherty to Assume Role of Chief Financial Officer on February 1, 2022
Surgery Partners, Inc. · Jan 10, 2022
SuperCom Announces New Wyoming Government Electronic Monitoring Contract
SuperCom, Ltd. · Jan 10, 2022
Summit Therapeutics Today Presents Its Company Vision at 40th Annual J.P. Morgan Healthcare Virtual Conference
Summit Therapeutics Inc. · Jan 10, 2022
StrategX Elements Corp. Begins Trading on the Canadian Securities Exchange
Strategx Elements Corp. · Jan 10, 2022
StraightUp Resources Announces $1.5 Million Dollar Financing
Battery X Metals Inc. · Jan 10, 2022
Steve Madden Announces Two New Appointments to Board of Directors
Steven Madden, Ltd. · Jan 10, 2022
STAAR Surgical Announces Preliminary Fourth Quarter and Full Year 2021 Results
STAAR Surgical Company · Jan 10, 2022
Solstice Gold Further Consolidates Land Holdings in the Red Lake Gold Camp
Solstice Gold Corp. · Jan 10, 2022
Solid Biosciences Outlines its Strategic Priorities for 2022 and Announces Corporate Updates
Solid Biosciences Inc. · Jan 10, 2022
SK geo centric and PureCycle Announce Location of Asia's First Polypropylene Recycling Plant
PureCycle Technologies, Inc. · Jan 10, 2022
SiriusXM Sets Fourth Quarter and Full-Year 2021 Earnings Date
Atlanta Braves Holdings, Inc. - Series A · Jan 10, 2022
SiriusXM Sets Fourth Quarter and Full-Year 2021 Earnings Date
SiriusXM Holdings Inc. · Jan 10, 2022
Sight Sciences Announces Preliminary Unaudited Fourth Quarter and Full Year 2021 Financial Results
Sight Sciences, Inc. · Jan 10, 2022
SIGA Technologies Receives Approval from the European Medicines Agency for Tecovirimat
SIGA Technologies Inc. · Jan 10, 2022
SI-BONE Announces Revenue for the Fourth Quarter and Full Year 2021
SI-BONE, Inc. · Jan 10, 2022
Sema4 Announces Preliminary Revenue for the Fourth Quarter and Fiscal Year 2021
GeneDx Holdings Corp. · Jan 10, 2022
Scholar Rock Provides Corporate Update and Highlights Priorities for 2022
Scholar Rock Holding Corporation · Jan 10, 2022
Sarepta Therapeutics’ Gene Therapy SRP-9001 Shows Statistically Significant Functional Improvements Compared to Pre-specified Matched Ext...
Sarepta Therapeutics, Inc. · Jan 10, 2022
Sana Biotechnology, IASO Biotherapeutics, and Innovent Biologics Announce Non-Exclusive License Agreement for Clinically Validated BCMA C...
Sana Biotechnology, Inc. · Jan 10, 2022
Saia to Announce Fourth Quarter 2021 Results on February 2, 2022
Saia, Inc. · Jan 10, 2022
Sabra Health Care REIT, Inc. to Participate in the Bank of America Virtual West Coast Tour
Sabra Health Care REIT, Inc. · Jan 10, 2022
Royalty Pharma Highlights Accomplishments and Provides Business Update at 40th Annual J.P. Morgan Healthcare Conference
Royalty Pharma plc · Jan 10, 2022
Robinhood Markets, Inc. to Announce Fourth Quarter and Full Year 2021 Results on January 27, 2022
Robinhood Markets, Inc. · Jan 10, 2022
Reviva Pharmaceuticals Holdings, Inc. Receives FDA May Proceed Letter for Pivotal Phase 3 Clinical Trial and Long-Term Safety Trial Evalu...
Reviva Pharmaceuticals Holdings, Inc. · Jan 10, 2022
Replimune Provides 2021 Year End Review and Overview of Expected 2022 Milestones
Replimune Group, Inc. · Jan 10, 2022
REGENXBIO Announces Initiation of Second Pivotal Trial in RGX-314 Clinical Program for the Treatment of Wet AMD Using Subretinal Delivery
Regenxbio Inc. · Jan 10, 2022
Ranchero Gold Announces Appointment of Brian Szeto as President
Ranchero Gold Corp · Jan 10, 2022
Pure Cycle Reports First Quarter Results
Pure Cycle Corporation · Jan 10, 2022
PTC Therapeutics Provides an Update on Commercial Progress and R&D Pipeline at 40th Annual J.P. Morgan Healthcare Conference
PTC Therapeutics, Inc. · Jan 10, 2022
Protara Therapeutics Announces Appointment of Jathin Bandari, M.D. as Chief Medical Officer
Protara Therapeutics, Inc. · Jan 10, 2022
Plug Power to Provide Annual Business Update on January 19, 2022
Plug Power, Inc. · Jan 10, 2022
Plains All American Pipeline and Plains GP Holdings Announce Timing of Fourth-Quarter and Full-Year 2021 Earnings
Plains All American Pipeline, L.P. · Jan 10, 2022
Plains All American Pipeline and Plains GP Holdings Announce Timing of Fourth-Quarter and Full-Year 2021 Earnings
Plains GP Holdings, L.P. · Jan 10, 2022
Pizza Hut® and Beyond Meat® Strengthen Partnership With Debut of Beyond Italian Sausage™ Crumbles at Locations Across Canada
Beyond Meat, Inc. · Jan 10, 2022
Pfizer and Beam Enter Exclusive Multi-Target Research Collaboration to Advance Novel In Vivo Base Editing Programs for a Range of Rare Di...
Beam Therapeutics Inc. · Jan 10, 2022
PetMeds® Appoints Three New Key Executives
PetMed Express, Inc. · Jan 10, 2022
Perion Network to Announce Fourth Quarter and Annual 2021 Financial Results on February 9, 2022
Perion Network Ltd · Jan 10, 2022
PDS Biotech Granted Patent for its Novel HPV16 Immunotherapy
PDS Biotechnology Corporation · Jan 10, 2022
Passage Bio Announces 2022 Research and Clinical Development Goals to Advance Robust CNS Pipeline
Passage Bio, Inc. · Jan 10, 2022
Osisko Gold Royalties Announces Preliminary Q4 2021 Deliveries and Provides 2021 Recap and Portfolio Update
OR Royalties Inc. · Jan 10, 2022
OrthoPediatrics Announces Preliminary Unaudited Revenue for the Fourth Quarter & Full-Year 2021
OrthoPediatrics Corp. · Jan 10, 2022
Orthofix Announces Preliminary 2021 Fourth Quarter and Full Year Net Sales Results
Orthofix Medical Inc. · Jan 10, 2022
Organovo Files Counterclaims In Patent Lawsuit Brought Against It by CellInk
VivoSim Labs, Inc. · Jan 10, 2022
OneSpaWorld Provides Preliminary Revenues for Q4 2021 Ahead of its Fireside Chat Presentation at the ICR Conference Today, January 10, 2022
OneSpaWorld Holdings Limited · Jan 10, 2022
OneSpan to Announce Fourth Quarter and Fiscal Year 2021 Financial Results on February 22, 2022
OneSpan Inc. · Jan 10, 2022
Nutriband Inc. And Kindeva Drug Delivery Sign Feasibility Agreement to Develop AVERSA(TM) Fentanyl, an Abuse Deterrent Fentanyl Patch
Nutriband Inc. · Jan 10, 2022
Nurix Therapeutics Advances Clinical and Preclinical Pipeline and Outlines 2022 Catalysts
Nurix Therapeutics, Inc. · Jan 10, 2022
Novocure Announces Preliminary Full Year and Fourth Quarter 2021 Net Revenues and Provides Company Update
NovoCure Limited · Jan 10, 2022
Novavax and Serum Institute of India File for Emergency Use Authorization of Novavax' COVID-19 Vaccine in South Africa
Novavax, Inc. · Jan 10, 2022
Nouveau Monde Graphite Appoints Bernard Perron as Chief Operating Officer in Preparation for the Scale Up of its Anode Material Production
Nouveau Monde Graphite Inc · Jan 10, 2022
Northern Lights Resources Secret Pass Project - Soil Geochemistry Results
Northern Lights Resources Corp · Jan 10, 2022
Noodles & Company Announces Signing of 55 Restaurant Franchise Deal in California with Warner Foods
Noodles & Company · Jan 10, 2022
NioBay Metal announces agreement with Tribal Logistics/Expedition Helicopter and updated agreement with Moose Cree First Nation
Niobay Metals Inc. · Jan 10, 2022
Newfoundland Discovery Commences Winter Drilling of up to 10,000 metres at the Chubb Lithium Project, Quebec
Genesis Goldfields Corp. · Jan 10, 2022
New Faces on Board at First Guaranty Bank
First Guaranty Bancshares, Inc. · Jan 10, 2022
Neuronetics Reports Preliminary Fourth Quarter and Fiscal Year 2021 Financial Results
Neuronetics, Inc. · Jan 10, 2022
Neoleukin Therapeutics Presenting at H.C. Wainwright BIOCONNECT Virtual Conference
Neurogene Inc. · Jan 10, 2022
Neoleukin Therapeutics Announces Clinical Collaboration with Merck to Evaluate NL-201 in Combination with KEYTRUDA® (pembrolizumab)
Neurogene Inc. · Jan 10, 2022
nCino Completes Acquisition of SimpleNexus
nCino, Inc. · Jan 10, 2022
Nasdaq December 2021 Volumes and 4Q21 Statistics
Nasdaq, Inc. · Jan 10, 2022
Moderna Announces Advances Across Its Industry-Leading mRNA Pipeline and Provides Business Update
Moderna, Inc. · Jan 10, 2022
MKS Withdraws from Photonics West 2022
MKS Inc. · Jan 10, 2022